Helen Y. Chu, MD, MPH
Associate Professor of Medicine and Epidemiology
University of Washington
Dr. Chu is Associate Professor at the University of Washington Schools of Medicine and Public Health, and an expert on respiratory viruses and vaccines. She has made substantial contributions to the COVID response in Washington State. Along with a team of scientists, she leads the Seattle Flu Study, a study focused on pandemic preparedness which first identified COVID-19 community transmission in the United States. She established the first cohort of COVID-19 survivors in the United States, which allowed for major early contributions to development of treatments and vaccines for SARS-CoV-2. She has worked closely with local public schools in Snohomish, Seattle, and Yakima to do studies in young children to understand testing and school-based transmission, and has led the Husky Coronavirus Testing program, the testing program for University of Washington students, faculty, and staff. She has also worked with multiple other underserved populations including the homeless populations in Seattle. She serves on the NIH Expert Working Groups for Maternal COVID Vaccines, COVID, and Respiratory Viruses. As an acknowledgment of her contribution to the state-wide COVID response, she received the Researcher of the Year Award from the Puget Sound Business Journal, the SHERO award from the National Organization for Women, the UW School of Public Health Changemakers Award, the Seattle Mariners Hometown Hero Award, the Seattle Seahawks 12 Flag Raiser, and the Washingtonian of the Year Award from the State of Washington.
XinQi Dong, MD, MPH
Director, Institute for Health, Health Care Policy and Aging Research
Henry Rutgers Distinguished Professor of Population Health Sciences
Rutgers University-New Brunswick
Professor XinQi Dong is director of the Institute for Health, Health Care Policy, and Aging Research (IFH) at Rutgers as well as the inaugural Henry Rutgers Distinguished Professor of Population Health Sciences. Professor Dong has published extensively on the topic of violence prevention with more than 200 peer-reviewed publications and is leading a longitudinal epidemiological study (The PINE Study) of 3,300 Chinese older adults to quantify relationships among culture, violence, and health outcomes.
Professor Dong was appointed a member of the Institute of Medicine’s Global Violence Prevention Forum and then chaired the workshop on elder abuse prevention. An epidemiologist and health services researcher whose research focuses on aging populations and the intersection of culture, resilience, and health outcomes, Professor Dong has been a strong advocate for advancing health issues in underrepresented communities worldwide.
Victor J. Dzau, MD
President, National Academy of Medicine
Vice Chair, National Research Council
Victor J. Dzau, MD is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine (IOM), US. In addition, he serves as Vice Chair of the National Research Council.
Dr. Dzau has made a significant impact on health and medicine through his seminal research in cardiovascular medicine and genetics and his leadership in health innovation. His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as widely used, lifesaving drugs. His pioneering research in cardiovascular regeneration led to the Paracrine Hypothesis of stem cell action and the strategy of direct cardiac reprogramming. In his role as a leader in health, Dr. Dzau has led efforts in innovation to improve health, including the founding of the Harvard BWH Division of Global Equity, the International Partnership in Innovation in Healthcare, the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation, and recently participated in the founding of the Coalition for Epidemic Preparedness and Innovation.
Since arriving at the National Academies, Dr Dzau has emphasized leadership, innovation, and impact. He has led important initiatives such as the Global Health Risk Framework for the Future, the Human Gene Editing Initiative, Vital Directions for Health and Healthcare, and Grand Challenges in Health and Medicine. His vision is to advance science, medicine, and policy to improve health globally.
Hanson Hsu, MD
Physician IT Liaison, NewYork-Presbyterian
Attending Physician, Department of Emergency Medicine, NYP-WCMC
Assistant Professor, Clinical Emergency Medicine, Weill Cornell Medical College
Dr. Hsu has been instrumental in promoting and adapting telehealth during the
COVID-19 pandemic within New York Presbyterian and Weill Cornell Medical Center.
Shari M. Ling, MD
Deputy Chief Medical Officer
Centers for Medicare and Medicaid Services
Center for Clinical Standards and Quality
Dr. Shari M. Ling is currently the Centers for Medicare and Medicaid Services (CMS), Deputy Chief Medical Officer serving in the Center for Clinical Standards and Quality (CCSQ), responsible for assisting the CMS Chief Medical Officer in the Agency's pursuit of higher quality health care, healthier populations, and lower cost through quality improvement. Dr. Ling's long-standing focus is on the achievement of meaningful health outcomes through delivery of high quality beneficiary-centered care across all care settings, with a special interest in the care of persons with multiple chronic conditions and functional limitations, and reducing health disparities.
Dr. Ling has served as the lead coordinator and facilitator of the CCSQ Measures Forum. Dr. Ling represents CMS on the Health and Human Services (HHS) Multiple Chronic Conditions workgroup, and the National Quality Forum Measures Application Partnership Post-acute Care/Long-term Care workgroup, and chairs the Measures and Data sources sub-workgroup for the HHS Action Plan for Healthcare Associated Infection (HAI) Prevention in Long-term Care facilities. Dr. Ling also serves as the clinical sub-group lead for the HHS National Alzheimer's Project Act.
Dr. Ling is a Geriatrician and Rheumatologist who received her medical training at Georgetown University School of Medicine where she graduated as a member of the Alpha Omega Alpha Honor Society. Dr. Ling received her clinical training in Internal Medicine and Rheumatology at Georgetown University Medical Center, and completing Geriatric Medicine studies at Johns Hopkins University., remaining on faculty at Johns Hopkins for 5 years, after which she joined the Intramural Research Program of the National Institutes of Health at the National Institute on Aging as a Staff Clinician for 8 years studying human aging and age-associated chronic diseases with attention to musculoskeletal conditions and mobility function.
Dr. Ling continues to serve as a part-time faculty member in the Division of Geriatric Medicine and Gerontology at Johns Hopkins University School of Medicine, and in the Division of Rheumatology, Allergy and Clinical Immunology at the University of Mary-land. Dr. Ling volunteers at the Veterans Administration Medical Center in Baltimore. She is a Gerontologist who received her training in Direct Service from the Ethel Percy Andrus Gerontology Center, at the University of Southern California, and served as the co-director of the Andrus Older Adult Counseling Center.
Dr. Ling resides in Maryland, is married and has two children.
New York Regional Administrator
Centers for Medicare & Medicaid Services
As Regional Administrator and Staff Director for CMS New York, Kathleen Otte leads and
coordinates local external engagement efforts with all regional stakeholders and customers in New
Jersey and New York. She also provides administrative and operational support to all employees
in CMS New York, promoting cohesion and collaboration throughout the regional office and with
other CMS components. Manage, oversee, and coordinate space and facility operations for all staff
assigned to the New York Regional Office. Serve as CMS' primary official for New York and New
Jersey. Responds to requests for information, media interviews and coordination with other CMS
components. Develop and foster collaborative partnerships and engagement opportunities with
stakeholders that enhance policy, operations, and other enterprise interests/initiatives designed to
enhance health care quality, value, and access to coverage. Develop and set the internal
agenda/strategy and plan for building and assuring external public campaign operations and
messaging for various outreach and awareness campaigns at the regional and local levels.
Strengthen engagement and partnerships with a variety of CMS stakeholders while promoting
awareness of all CMS programs through outreach and education.
Litjen (L.J.) Tan, MS, PhD
Chief Strategy Officer, Immunization Action Coalition
Co-Chair, National Adult Immunization Summit and National Influenza Vaccine Summit
Prior to joining the Immunization Action Coalition (IAC), Dr. Tan was the director of medicine and public health at the American Medical Association (AMA) a position he held since 2008. From 1997 to 2008, he was the AMA's director of infectious disease, immunology, and molecular medicine.
Dr. Tan was a voting member of the Department of Health and Human Services' National Vaccine Advisory Committee from 2009 to 2013, where he served on the adult immunization, vaccine safety, and healthcare worker immunization working groups, and chaired the immunization infrastructure working group. For more than ten years, he was the AMA's liaison to the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, where he served on the influenza, pneumococcal, zoster, and adult immunization working groups.
He co-founded and currently co-chairs the National Adult and Influenza Immunization Summit. He serves or has served on the steering committees/advisory boards of the 317 Coalition, the Adult Vaccine Access Coalition (AVAC), the Unity (United for Adolescent Vaccination) Consortium, the National Network for Immunization Information, and the National Viral Hepatitis Roundtable and on the IAC scientific advisory board. Dr. Tan has also serves, or has served, on the National Quality Forum's Adult Immunizations Expert Committee, the Pharmacy Quality Alliance's Adult Immunization Working Group, and numerous national and international expert and technical advisory committees, including panels for the Centers for Medicare and Medicaid Services, The Joint Commission, and the Centers for Disease Control and Prevention, on issues ranging from vaccine hesitancy, immunization quality measurement development, adult immunizations, to immunization access and delivery. In 2007, he founded the National Immunization Congress and organized its 2007 and 2010 meetings.
Dr. Tan received his Master of Science degree in biology at New York University and earned his PhD in microbiology/immunology from Northwestern University Feinberg School of Medicine in Chicago. Dr. Tan is an editor for Vaccine, BMC Infectious Diseases, Medscape Infectious Diseases, and a member of the ESCMID Vaccine Study Group and has published more than 50 peer-reviewed articles. During his tenure at the AMA, he wrote numerous scientific reports to guide the association's policies on a diverse range of public health topics. A skilled and sought-after speaker, Dr. Tan has been invited to address international, national, and state immunization audiences on issues ranging from vaccine financing to risk management in vaccine safety to emerging infectious diseases.
Dr. Tan has received several awards for his advocacy work including the 2011 CDC National Center for Immunization and Respiratory Diseases Honor Awards: Excellence in Partnering recognition, and most recently was awarded the American Pharmacists Association's national Friend of Pharmacy Award. As a former part-time faculty member at the Institute for Science Education and Science Communication, Columbia College, Chicago, he received the 2000 Excellence in Teaching Award.
Winston F. Wong, MD, MS
Chair, National Council of Asian Pacific Islander Physicians
Scholar-in-Residence, UCLA Kaiser Permanente Center for Health Equity
Winston Wong, MD, MS, FAAFP, is a Scholar in Residence at the UCLA Kaiser Permanente
Center for Health Equity at the Fielding School of Public Health, UCLA. A fellow of the
American Academy of Family Practice, Dr. Wong’s professional career has encompassed
leadership roles at community health centers, federal service and most recently at Kaiser
Permanente, where he served as Medical Director for Community Benefit for over 17 years. His
commitment to addressing health equity is anchored by his experience as a bilingual primary
care community health center physician for the Asian immigrant community in Oakland
Chinatown, which led him to leadership roles in the United States Public Health Service, where
he served as HRSA’s chief Clinical Officer for a region than spanned the Pacific and western
United States. At Kaiser Permanente, he was responsible for its national philanthropic
strategies to support clinical and population management initiatives with the safety net, and for
its quality initiatives to address disparities within its 12 million membership. In 2016 he was
appointed to the US DHHS Advisory Committee on Minority Health, and in 2019 was appointed
chair. At the NASEM he chairs the Roundtable on Health Equity, and has served on the Board
of Population Health and Public Health Practice. As a leader in philanthropy, he has active
Board roles at the California Endowment and Grantmakers in Health. He also previously served
as Board Chair for the School Based Health Alliance and is the current acting CEO and Chair of
the National Council of Asian Pacific Islander Physicians. His work in developing programs and
policies to address health equity has been recognized by awards from the California Primary
Care Association, Latino Health Access, the Minority Health Foundation, Asian Health Services,
and Congresswoman Barbara Lee. In addition to his 2020 Scholar in Residence appointment at
UCLA, Dr. Wong received a Doctor or Humane Letters from the A.T. Still of Osteopathic
Michael Chang is a fourth-year medical student at Harvard Medical School, with plans to pursue residency training in dermatology. He graduated from Princeton University with a Bachelor's in Molecular Biology. Under the mentorship of Dr. Rebecca Hartman, he has conducted dermatoepidemiological research at the Brigham and Women's Hospital/Dana-Farber Cancer Institute and the VA Boston Healthcare System. Michael is passionate about pursuing a future career focused on cutaneous oncology and health disparities research.
Elaine Cheung is a second-year medical student at California Northstate University College of Medicine, with plans to pursue training in internal medicine. She graduated from UCLA with a bachelor's degree in Neuroscience. With the support of Dr. Anne Saw and the Chicago Asian American Psychology Lab, she has conducted epidemiological research looking at community mental health disparities during the COVID-19 pandemic. Elaine is passionate about becoming a future physician-leader engaged in community health research and promoting health equity.
Joseph Chu, MD
Dr. Chu graduated from the Faculty of Medicine, University of Toronto in 1978. He subsequently completed his residency training in Internal Medicine and Neurology at University of Toronto obtaining his FRCPC in both specialties. He opened a private Neurological consultative practice in Etobicoke in 1984 with special interests in electromyography and clinical neuromuscular disorders. Other areas of interests include Stroke, Epilepsy, Movement Disorder including Botox injections and Dementia. He is an Assistant Professor of Medicine (Neurology) at the University of Toronto and is an associate staff Neurologist at the Toronto Western Hospital-University Health Network. He is also a consultant Neurologist at the William Osler Health System in Toronto. He was past president of the Chinese Canadian Medical Society of Ontario. In addition, he had published extensively in peer review journals on the Epidemiology of Cerebrovascular Diseases of Chinese-Canadians. He was the Chairman of the Research Committee, Chinese Canadian Council of the Heart & Stroke Foundation and now the Chinese Canadian Heart and Brain Association (CCHABA). He has been a popular invited visiting Professor giving lectures in Hong Kong, Peoples’ Republic of China, Taiwan and USA.
Frederick LuFrederick Lu is a medical student at the Boston University School of Medicine. Prior to medical school, he worked as an EMT, ER tech, and as a Research Assistant at the Health Equity Research Lab at the Cambridge Health Alliance/Harvard Medical School. He is a disparities focused health services researcher, with a particular interest in examining racial/ethnic inequities in healthcare.